The Cell Processing Facility supports the development and manufacture of innovative cell-based therapies for Phase I/II clinical testing. The facility permits the reproducible production of large-scale quantities of therapeutic cells under the strict quality control and safety conditions required by the FDA for human studies.
- Thomas Building, DE – 580
- Mailing Address:
- P.O. Box 19025, MS DE 580, Seattle, WA 98109-1024
- (206) 667-3196
- (206) 667-4498
- David Shank, Manager;
Shelly Heimfeld Ph.D., Scientific Advisor
A complete listing of Cell Processing employees is available from the directory.